Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1986-6-3
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0098-6577
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S104-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3457985-Adult,
pubmed-meshheading:3457985-Aged,
pubmed-meshheading:3457985-Aluminum,
pubmed-meshheading:3457985-Brain Diseases,
pubmed-meshheading:3457985-Deferoxamine,
pubmed-meshheading:3457985-Female,
pubmed-meshheading:3457985-Humans,
pubmed-meshheading:3457985-Kidney Failure, Chronic,
pubmed-meshheading:3457985-Male,
pubmed-meshheading:3457985-Middle Aged,
pubmed-meshheading:3457985-Renal Dialysis
|
pubmed:year |
1986
|
pubmed:articleTitle |
Role of desferrioxamine in the treatment of dialysis encephalopathy.
|
pubmed:publicationType |
Journal Article
|